Related Experiment Video

Updated: Mar 21, 2026

Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.7K

Will Testicular Germ Cell Tumors Remain Untargetable?

Fouad Aoun1, Hampig Raphael Kourie2, Simone Albisinni3

  • 1Department of Urology, Hôtel Dieu de France, Beyrouth, Lebanon. fouad.aoun@bordet.be.

Targeted Oncology
|May 18, 2016
PubMed

Insights

Testicular Germ Cell Tumors (TGCT) are common in young men. This review explores new insights into TGCT development, biomarkers, and treatment resistance, highlighting targeted therapy potential.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Testicular Germ Cell Tumors (TGCT) are the most frequent solid tumors in young males.
  • TGCTs possess a unique embryonic origin and distinct biological characteristics.
  • Recent research has illuminated TGCT pathogenesis, differentiation, and treatment resistance mechanisms.

Purpose of the Study:

  • To review recent advancements in understanding TGCT development, differentiation, and progression.
  • To evaluate novel epigenetic and molecular biomarkers for diagnostic and prognostic accuracy.
  • To analyze mechanisms of resistance to chemotherapy and explore potential targeted therapies for resistant TGCTs.

Main Methods:

  • Comprehensive literature review of preclinical and clinical data.
  • Analysis of genetic and epigenetic susceptibility profiles.
  • Examination of molecular patterns, signaling pathways, and pathogenesis.

Main Results:

  • New insights into TGCT pathogenesis and differentiation pathways have emerged.
  • Epigenetic and molecular biomarkers show promise compared to current standards.
  • Mechanisms of cisplatin resistance are detailed, with an analysis of targeted therapy trials.

Conclusions:

  • Understanding TGCT pathogenesis and resistance is advancing through molecular and epigenetic research.
  • Novel biomarkers offer improved diagnostic and prognostic potential.
  • Targeted therapies represent a promising avenue for managing resistant TGCTs.

More Related Videos

Mouse Round Spermatid Injection08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

1.6K
Teratoma Generation in the Testis Capsule05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.6K

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
658
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
124.5K